Researchers have developed a simple urine test to measure the severity of the serious disease cystic fibrosis and assess the effect of new treatments. Researchers have developed a simple urine test to ...

VIENNA — Advances in genetic testing and newly discovered biomarkers can help screen newborns and monitor inflammation and pulmonary exacerbations in patients diagnosed with cystic fibrosis. At the ...

Please provide your email address to receive an email when new articles are posted on . A recent document establishes standard operating procedures for exercise testing in patients with cystic ...

DEAR MAYO CLINIC: My 5-year-old daughter has been tested for cystic fibrosis twice. Both times the test has come up in the "gray area" in the 40s. The pulmonologist told us he does not know a lot ...

The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...

An easy-to-administer electrolyte test could offer new insight into response to treatment and disease progression for patients with cystic fibrosis. In a new study, researchers found that urine ...

All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to ...

North Carolina has joined 46 states in adding Cystic Fibrosis testing for all newborns. Typically, the inherited, chronic disease isn't diagnosed until a child starts to show symptoms. However, with ...

Objective:To describe the psychological reaction to information about diagnostic genetic testing for α-1 antitrypsin deficiency (Alpha-1) and cystic fibrosis (CF) in chronic obstructive pulmonary ...

Cystic fibrosis is caused by genetic changes and is always present at birth. Although rare, cystic fibrosis isn’t diagnosed in some people who have mild symptoms until they’re adults. This is known as ...

BOSTON (MarketWatch) -- Vertex Pharmaceuticals said Wednesday it has begun Phase I clinical testing of its drug candidate VX-770 for the treatment of cystic fibrosis, or CF. Currently there are few ...